{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:18:01Z","timestamp":1771604281164,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0965-5","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T10:13:34Z","timestamp":1544609614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Novel CHM mutations in Polish patients with choroideremia \u2013 an orphan disease with close perspective of treatment"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-1776","authenticated-orcid":false,"given":"Anna","family":"Skorczyk-Werner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wawrocka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Kochalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej Robert","family":"Krawczynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"key":"965_CR1","unstructured":"MacDonald IM, Hume S, Chan S, Seabra MC. Choroideremia. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, Amemiya A, editors. GeneReviews\u00ae. Seattle: University of Washington, Seattle; 1993\u20132018; 2003. Available from \n                    https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1337\/ \n                    \n                  PubMed PMID: 20301511. [updated 2015 Feb 26]."},{"issue":"4","key":"965_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1034\/j.1600-0420.2000.078004483.x","volume":"78","author":"K Endo","year":"2000","unstructured":"Endo K, Yuzawa M, Ohba N. Choroideremia associated with subretinal neovascular membrane. Acta Ophthalmol Scand. 2000;78(4):483\u20136 PubMed PMID: 10990059.","journal-title":"Acta Ophthalmol Scand"},{"issue":"11","key":"965_CR3","doi-asserted-by":"publisher","first-page":"2066.e1","DOI":"10.1016\/j.ophtha.2006.05.045","volume":"113","author":"AB Renner","year":"2006","unstructured":"Renner AB, Kellner U, Cropp E, Preising MN, MacDonald IM, van den Hurk JA, Cremers FP, Foerster MH. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram. Ophthalmology. 2006;113(11):2066.e1\u201310.","journal-title":"Ophthalmology"},{"issue":"10","key":"965_CR4","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/ajmg.a.32727","volume":"149A","author":"HJ Perez-Cano","year":"2009","unstructured":"Perez-Cano HJ, Garnica-Hayashi RE, Zenteno JC. CHM gene molecular analysis and X-chromosome inactivation pattern determination in two families with choroideremia. Am J Med Genet A. 2009;149A(10):2134\u201340.","journal-title":"Am J Med Genet A"},{"key":"965_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/hmg\/3.7.1041","volume":"3","author":"H Bokhoven van","year":"1994","unstructured":"van Bokhoven H, van den Hurk JA, Bogerd L, Philippe C, Gilgenkrantz S, de Jong P, Ropers HH, Cremers FP. Cloning and characterization of the human choroideremia gene. Hum Mol Genet. 1994;3:1041\u20136.","journal-title":"Hum Mol Genet"},{"issue":"5093","key":"965_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1126\/science.8380507","volume":"259","author":"MC Seabra","year":"1993","unstructured":"Seabra MC, Brown MS, Goldstein JL. Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase. Science. 1993;259(5093):377\u201381.","journal-title":"Science"},{"issue":"6","key":"965_CR7","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/0092-8674(93)90639-8","volume":"73","author":"DA Andres","year":"1993","unstructured":"Andres DA, Seabra MC, Brown MS, Armstrong SA, Smeland TE, Cremers FP, Goldstein JL. cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell. 1993;73(6):1091\u20139.","journal-title":"Cell"},{"key":"965_CR8","unstructured":"Leiden Open Variation Database (LOVD). \n                    http:\/\/www.lovd.nl\/3.0\/home\n                    \n                  . Accessed 11 June 2018."},{"key":"965_CR9","unstructured":"Human Gene Mutation Database (HGMD). \n                    http:\/\/www.hgmd.cf.ac.uk\/ac\/index.php\n                    \n                  . Accessed 11 June 2018."},{"issue":"14","key":"965_CR10","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1167\/iovs.16-20230","volume":"57","author":"MP Simunovic","year":"2016","unstructured":"Simunovic MP, Jolly JK, Xue K, Edwards TL, Groppe M, Downes SM, MacLaren RE. The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype. Invest Ophthalmol Vis Sci. 2016;57(14):6033\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"965_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mgg3.208","volume":"4","author":"PR Freund","year":"2016","unstructured":"Freund PR, Sergeev YV, MacDonald IM. Analysis of a large choroideremia datase does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy. Mol Genet Genomic Med. 2016;4(3):344\u201358.","journal-title":"Mol Genet Genomic Med"},{"issue":"5","key":"965_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/ICU.0000000000000392","volume":"28","author":"IS Dimopoulos","year":"2017","unstructured":"Dimopoulos IS, Radziwon A, St Laurent CD, MacDonald IM. Choroideremia. Curr Opin Ophthalmol. 2017;28(5):410\u20135.","journal-title":"Curr Opin Ophthalmol"},{"issue":"12","key":"965_CR13","doi-asserted-by":"publisher","first-page":"e81758","DOI":"10.1371\/journal.pone.0081758","volume":"8","author":"M K\u00f6hnke","year":"2013","unstructured":"K\u00f6hnke M, Delon C, Hastie ML, Nguyen UT, Wu YW, Waldmann H, Goody RS, Gorman JJ, Alexandrov K. Rab GTPase prenylation hierarchy and its potential role in choroideremia disease. PLoS One. 2013;8(12):e81758.","journal-title":"PLoS One"},{"issue":"6","key":"965_CR14","first-page":"1195","volume":"50","author":"JA Hurk van den","year":"1992","unstructured":"van den Hurk JA, van de Pol TJ, Molloy CM, Brunsmann F, R\u00fcther K, Zrenner E, Pinckers AJ, Pawlowitzki IH, Bleeker-Wagemakers EM, Wieringa B, et al. Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing. Am J Hum Genet. 1992;50(6):1195\u2013202.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"965_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/humu.1380020108","volume":"2","author":"M Schwartz","year":"1993","unstructured":"Schwartz M, Rosenberg T, van den Hurk JA, van de Pol DJ, Cremers FP. Identification of mutations in Danish choroideremia families. Hum Mutat. 1993;2(1):43\u20137.","journal-title":"Hum Mutat"},{"issue":"2","key":"965_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.3892\/ijmm.2014.1797","volume":"34","author":"S Li","year":"2014","unstructured":"Li S, Guan L, Fang S, Jiang H, Xiao X, Yang J, Wang P, Yin Y, Guo X, Wang J, Zhang J, Zhang Q. Exome sequencing reveals CHM mutations in six families with atypical choroideremia initially diagnosed as retinitis pigmentosa. Int J Mol Med. 2014;34(2):573\u20137.","journal-title":"Int J Mol Med"},{"issue":"6","key":"965_CR17","doi-asserted-by":"publisher","first-page":"35360","DOI":"10.1038\/srep35360","volume":"14","author":"XB Cai","year":"2016","unstructured":"Cai XB, Huang XF, Tong Y, Lu QK, Jin ZB. Novel CHM mutations identified in Chinese families with Choroideremia. Sci Rep. 2016;14(6):35360.","journal-title":"Sci Rep"},{"issue":"12","key":"965_CR18","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/humu.21591","volume":"32","author":"G Esposito","year":"2011","unstructured":"Esposito G, De Falco F, Tinto N, Testa F, Vitagliano L, Tandurella IC, Iannone L, Rossi S, Rinaldi E, Simonelli F, Zagari A, Salvatore F. Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat. 2011;32(12):1460\u20139.","journal-title":"Hum Mutat"},{"issue":"4","key":"965_CR19","doi-asserted-by":"publisher","first-page":"e0151943","DOI":"10.1371\/journal.pone.0151943","volume":"11","author":"R Sanchez-Alcudia","year":"2016","unstructured":"Sanchez-Alcudia R, Garcia-Hoyos M, Lopez-Martinez MA, Sanchez-Bolivar N, Zurita O, Gimenez A, Villaverde C, Rodrigues-Jacy da Silva L, Corton M, Perez-Carro R, Torriano S, Kalatzis V, Rivolta C, Avila-Fernandez A, Lorda I, Trujillo-Tiebas MJ, Garcia-Sandoval B, Lopez-Molina MI, Blanco-Kelly F, Riveiro-Alvarez R, Ayuso C. A comprehensive analysis of Choroideremia: from genetic characterization to clinical practice. PLoS One. 2016;11(4):e0151943.","journal-title":"PLoS One"},{"issue":"4","key":"965_CR20","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.1380080405","volume":"8","author":"L Beaufr\u00e8re","year":"1996","unstructured":"Beaufr\u00e8re L, Tuffery S, Hamel C, Arnaud B, Demaille J, Claustres M. A novel mutation (S558X) causing choroideremia. Hum Mutat. 1996;8(4):395.","journal-title":"Hum Mutat"},{"key":"965_CR21","unstructured":"Genetic Variant Interpretation Tool. \n                    http:\/\/www.medschool.umaryland.edu\/Genetic_Variant_Interpretation_Tool1.html\/\n                    \n                  . Accessed 14 May 2018."},{"issue":"9","key":"965_CR22","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0161-6420(98)99031-5","volume":"105","author":"IM MacDonald","year":"1998","unstructured":"MacDonald IM, Mah DY, Ho YK, Lewis RA, Seabra MC. A practical diagnostic test for choroideremia. Ophthalmology. 1998;105(9):1637\u201340.","journal-title":"Ophthalmology"},{"issue":"2","key":"965_CR23","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000437348","volume":"6","author":"K Shimizu","year":"2015","unstructured":"Shimizu K, Oishi A, Oishi M, Ogino K, Morooka S, Sugahara M, Gotoh N, Yoshimura N. Next-generation sequencing-based molecular diagnosis of Choroideremia. Case Rep Ophthalmol. 2015;6(2):246\u201350.","journal-title":"Case Rep Ophthalmol"},{"key":"965_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12886-015-0081-4","volume":"15","author":"H Guo","year":"2015","unstructured":"Guo H, Li J, Gao F, Li J, Wu X, Liu Q. Whole-exome sequencing reveals a novel CHM gene mutation in a family with choroideremia initially diagnosed as retinitis pigmentosa. BMC Ophthalmol. 2015;15:85.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"965_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1076\/1381-6810(200009)2131-ZFT185","volume":"21","author":"IJ Lorda-Sanchez","year":"2000","unstructured":"Lorda-Sanchez IJ, Iba\u00f1ez AJ, Sanz RJ, Trujillo MJ, Anabitarte ME, Querejeta ME, Rodriguez de Alba M, Gimenez A, Infantes F, Ramos C, Garcia-Sandoval B, Ayuso C. Choroideremia, sensorineural deafness, and primary ovarian failure in a woman with a balanced X-4 translocation. Ophthalmic Genet. 2000;21(3):185\u20139.","journal-title":"Ophthalmic Genet"},{"issue":"3","key":"965_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00439-003-0970-0","volume":"113","author":"JA Hurk van den","year":"2003","unstructured":"van den Hurk JA, van de Pol DJ, Wissinger B, van Driel MA, Hoefsloot LH, de Wijs IJ, van den Born LI, Heckenlively JR, Brunner HG, Zrenner E, Ropers HH, Cremers FP. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon. Hum Genet. 2003;113(3):268\u201375.","journal-title":"Hum Genet"},{"issue":"9923","key":"965_CR27","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S0140-6736(13)62117-0","volume":"383","author":"RE MacLaren","year":"2014","unstructured":"MacLaren RE, Groppe M, Barnard AR, Cottriall CL, Tolmachova T, Seymour L, Clark KR, During MJ, Cremers FP, Black GC, Lotery AJ, Downes SM, Webster AR, Seabra MC. Retinal gene therapy in patients with choroideremia: initial findings from a phase 1\/2 clinical trial. Lancet. 2014;383(9923):1129\u201337.","journal-title":"Lancet"},{"issue":"1","key":"965_CR28","doi-asserted-by":"publisher","first-page":"8234","DOI":"10.1038\/s41598-018-26481-7","volume":"8","author":"S Torriano","year":"2018","unstructured":"Torriano S, Erkilic N, Baux D, Cereso N, De Luca V, Meunier I, Moosajee M, Roux AF, Hamel CP, Kalatzis V. The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy. Sci Rep. 2018;8(1):8234.","journal-title":"Sci Rep"},{"issue":"16","key":"965_CR29","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1093\/hmg\/ddw184","volume":"25","author":"M Moosajee","year":"2016","unstructured":"Moosajee M, Tracey-White D, Smart M, Weetall M, Torriano S, Kalatzis V, da Cruz L, Coffey P, Webster AR, Welch E. Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model. Hum Mol Genet. 2016;25(16):3416\u201331.","journal-title":"Hum Mol Genet"},{"key":"965_CR30","unstructured":"Clinical Trials.gov: \n                    https:\/\/www.clinicaltrials.gov\/\n                    \n                  . Accessed 11 June 2018."},{"key":"965_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2018.06.011","volume":"193","author":"IS Dimopoulos","year":"2018","unstructured":"Dimopoulos IS, Hoang SC, Radziwon A, Binczyk NM, Seabra MC, MacLaren RE, Somani R, Tennant MTS, MacDonald IM. Two-year results after AAV2-mediated gene therapy for Choroideremia: the Alberta experience. Am J Ophthalmol. 2018;193:130\u201342.","journal-title":"Am J Ophthalmol"},{"key":"965_CR32","doi-asserted-by":"publisher","unstructured":"Lam BL, Davis JL, Gregori NZ, MacLaren RE, Girach A, Verriotto JD, Rodriguez B, Rosa PR, Zhang X, Feuer WJ. Choroideremia gene therapy phase 2 clinical trial: 24-month results. Am J Ophthalmol. 2018. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2018.09.012\n                    \n                  .","DOI":"10.1016\/j.ajo.2018.09.012"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0965-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0965-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T19:12:57Z","timestamp":1576091577000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0965-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["965"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0965-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"26 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the tenets of the Declaration of Helsinki and the Association for Research in Vision and Ophthalmology (ARVO) statement on human subjects. Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"221"}}